Liposomes as carriers for polymyxins in the treatment of cystic fibrosis lung infections

Eradication of mucoid Pseudomonas aeruginosa with fluid liposome-encapsulated tobramycin in an animal model of chronic pulmonary infection

Beaulieu, Christian
Cl\ue9ment-Major, S\ue9bastien
Al-Hawari, Jalal
Lagac\ue9, Jacqueline

March 1996

Despite controversies associated with forms and value of antibiotic therapy for cystic \ufb01brosis ...

Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis

Alipour, Misagh
Suntres, Zacharias E.
Halwani, Majed
Azghani, Ali
Omri, Abdelwahab

May 2009

Background: To compare the effectiveness of liposomal tobramycin or polymyxin B against Pseudomonas ...

Treatment of cystic fibrosis

Hussey, R.
Seddon, D
Liverpool Health Authorities (United Kingdom)

January 1994

SIGLEAvailable from British Library Document Supply Centre- DSC:5815.3675(69) / BLDSC - British Libr...

Liposomes as carriers for polymyxins in the treatment of cystic fibrosis lung infections

McAllister, Stephen M.

Cystic fibrosis (CF) is the most common autosomal recessive disorder affecting Caucasian populations...

Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with

Cystic Fibrosis
Misagh Alipour
Zacharias E. Suntres
Majed Halwani
Ali O. Azghani
Abdelwahab Omri

August 2016

Background: To compare the effectiveness of liposomal tobramycin or polymyxin B against Pseudomonas ...

Use of liposomes and cytokines as immunological adjuvants in vaccines

Gursel, M.

January 1995

SIGLEAvailable from British Library Document Supply Centre-DSC:DXN010755 / BLDSC - British Library D...

Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infections

Chalmers, J.D.
Ingen, J. van
Laan, Roald van der
Herrmann, J.L.

January 2021

Contains fulltext : 236899.pdf (Publisher’s version ) (Open Access

Development of Liposomal Ciprofloxacin to Treat Lung Infections

David Cipolla

March 2016

Except for management of Pseudomonas aeruginosa (PA) in cystic fibrosis, there are no approved inhal...

Pulmonary Target Delivery of Polymyxin B for Enhanced Efficacy

He, Jie 1981-

March 2018

Objective: Polymyxin B is increasingly used as the last resort for multidrug resistant (MDR) Gram-ne...

Bactericidal efficacy of liposomal aminoglycosides against Burkholderia cenocepacia

Majed Halwani
Clement Mugabe
Ali O. Azghani
Robert M. Lafrenie
Aseem Kumar
Abdelwahab Omri

August 2015

genomovar III) has emerged as a serious opportunistic pathogen in individuals with cystic fibrosis. ...

Inhaled Liposomal Antimicrobial Delivery in Lung Infections

Bassetti, Matteo
Vena, Antonio
Russo, Alessandro
Peghin, Maddalena

January 2020

The management of difficult-to-treat acute and chronic respiratory infections (infections in cystic ...

Some studies on liposomes as a drug delivery system

Mounajed, R
Brighton Polytechnic (United Kingdom)
Council for National Academic Awards (CNAA), London (United Kingdom)

January 1981

SIGLEAvailable from British Library Document Supply Centre- DSC:D37754/81 / BLDSC - British Library ...

New delivery systems-liposomes for pulmonary delivery of antibacterial drugs

Elhissi, A. M.
Dennison, S. R.
Ahmed, W.
Taylor, K. M.
Phoenix, D. A.

November 2014

Liposomes are established drug carriers for inhalation owing to their biocompatibility, biodegradabi...

The application of liposomes for solubilisation of hydrophobic drugs

Leigh, M.L.S.

January 1997

SIGLEAvailable from British Library Document Supply Centre-DSC:DX202330 / BLDSC - British Library Do...

Formulation and efficacy of liposome-encapsulated azithromycin for pulmonary infection due to Pseudomonias Aeruginosa

Solleti, Venkata Saran Tejaswi

May 2016

Cystic fibrosis is the most common life-threatening autosomal recessive disorder in Caucasians. Recu...

Eradication of mucoid Pseudomonas aeruginosa with fluid liposome-encapsulated tobramycin in an animal model of chronic pulmonary infection

Beaulieu, Christian
Cl\ue9ment-Major, S\ue9bastien
Al-Hawari, Jalal
Lagac\ue9, Jacqueline

March 1996

Despite controversies associated with forms and value of antibiotic therapy for cystic \ufb01brosis ...

Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis

Alipour, Misagh
Suntres, Zacharias E.
Halwani, Majed
Azghani, Ali
Omri, Abdelwahab

May 2009

Background: To compare the effectiveness of liposomal tobramycin or polymyxin B against Pseudomonas ...

Treatment of cystic fibrosis

Hussey, R.
Seddon, D
Liverpool Health Authorities (United Kingdom)

January 1994

SIGLEAvailable from British Library Document Supply Centre- DSC:5815.3675(69) / BLDSC - British Libr...

Liposomes as carriers for polymyxins in the treatment of cystic fibrosis lung infections

McAllister, Stephen M.

Cystic fibrosis (CF) is the most common autosomal recessive disorder affecting Caucasian populations...

Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with

Cystic Fibrosis
Misagh Alipour
Zacharias E. Suntres
Majed Halwani
Ali O. Azghani
Abdelwahab Omri

August 2016

Background: To compare the effectiveness of liposomal tobramycin or polymyxin B against Pseudomonas ...

Use of liposomes and cytokines as immunological adjuvants in vaccines

Gursel, M.

January 1995

SIGLEAvailable from British Library Document Supply Centre-DSC:DXN010755 / BLDSC - British Library D...

Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infections

Chalmers, J.D.
Ingen, J. van
Laan, Roald van der
Herrmann, J.L.

January 2021

Contains fulltext : 236899.pdf (Publisher’s version ) (Open Access

Development of Liposomal Ciprofloxacin to Treat Lung Infections

David Cipolla

March 2016

Except for management of Pseudomonas aeruginosa (PA) in cystic fibrosis, there are no approved inhal...

Pulmonary Target Delivery of Polymyxin B for Enhanced Efficacy

He, Jie 1981-

March 2018

Objective: Polymyxin B is increasingly used as the last resort for multidrug resistant (MDR) Gram-ne...

Bactericidal efficacy of liposomal aminoglycosides against Burkholderia cenocepacia

Majed Halwani
Clement Mugabe
Ali O. Azghani
Robert M. Lafrenie
Aseem Kumar
Abdelwahab Omri

August 2015

genomovar III) has emerged as a serious opportunistic pathogen in individuals with cystic fibrosis. ...

Inhaled Liposomal Antimicrobial Delivery in Lung Infections

Bassetti, Matteo
Vena, Antonio
Russo, Alessandro
Peghin, Maddalena

January 2020

The management of difficult-to-treat acute and chronic respiratory infections (infections in cystic ...

Some studies on liposomes as a drug delivery system

Mounajed, R
Brighton Polytechnic (United Kingdom)
Council for National Academic Awards (CNAA), London (United Kingdom)

January 1981

SIGLEAvailable from British Library Document Supply Centre- DSC:D37754/81 / BLDSC - British Library ...

New delivery systems-liposomes for pulmonary delivery of antibacterial drugs

Elhissi, A. M.
Dennison, S. R.
Ahmed, W.
Taylor, K. M.
Phoenix, D. A.

November 2014

Liposomes are established drug carriers for inhalation owing to their biocompatibility, biodegradabi...

The application of liposomes for solubilisation of hydrophobic drugs

Leigh, M.L.S.

January 1997

SIGLEAvailable from British Library Document Supply Centre-DSC:DX202330 / BLDSC - British Library Do...

Formulation and efficacy of liposome-encapsulated azithromycin for pulmonary infection due to Pseudomonias Aeruginosa

Solleti, Venkata Saran Tejaswi

May 2016

Cystic fibrosis is the most common life-threatening autosomal recessive disorder in Caucasians. Recu...

Eradication of mucoid Pseudomonas aeruginosa with fluid liposome-encapsulated tobramycin in an animal model of chronic pulmonary infection

Beaulieu, Christian
Cl\ue9ment-Major, S\ue9bastien
Al-Hawari, Jalal
Lagac\ue9, Jacqueline

March 1996

Despite controversies associated with forms and value of antibiotic therapy for cystic \ufb01brosis ...

Activity and Interactions of Liposomal Antibiotics in Presence of Polyanions and Sputum of Patients with Cystic Fibrosis

Alipour, Misagh
Suntres, Zacharias E.
Halwani, Majed
Azghani, Ali
Omri, Abdelwahab

May 2009

Background: To compare the effectiveness of liposomal tobramycin or polymyxin B against Pseudomonas ...

Treatment of cystic fibrosis

Hussey, R.
Seddon, D
Liverpool Health Authorities (United Kingdom)

January 1994

SIGLEAvailable from British Library Document Supply Centre- DSC:5815.3675(69) / BLDSC - British Libr...

Liposomes as carriers for polymyxins in the treatment of cystic fibrosis lung infections

Abstract

Extracted data

Liposomes as carriers for polymyxins in the treatment of cystic fibrosis lung infections

Abstract

Extracted data

Related items

Related items